Today, PICI announced its 2026 class of Early Career Researchers awardees. The investigators will receive more than $1 million in combined funding to advance innovative research projects that could help shape the next generation of cancer immunotherapies.
Meet the 2026 Early Career Researcher Awardees:
🔬 Sophie Louise Gray-Gaillard,
@PennMedicine
🔬 Jingya Qiu, PhD,
@GladstoneInst
🔬 Xinyu Xiang,
@StanfordMed
🔬 Shaobo Yang, PhD,
@DanaFarber
🔬 Maxime Meylan, PhD,
@DanaFarber
From programmable bacterial “living medicines” and tumor-targeting T-cell therapies to new approaches for understanding the tumor microenvironment and detecting cancer earlier, these researchers are pursuing high-risk, high-reward science with the potential to transform cancer treatment.
Now in its 10th year, PICI’s Early Career Researcher Awards program has invested $23.9 million across 63 research projects, giving emerging scientists the funding, resources and collaborative network to turn bold ideas into breakthroughs.
Learn more here:
parkerici.org/the-latest/pic…